Value
9.2/10data confidence 67%| Component | Sub-score |
|---|---|
| P/E | 8.5 |
| P/S | 9.2 |
| EV/EBITDA | 6.1 |
| PEG | 10.0 |
- ▸PEG: 0.12
- ▸Attractively valued
WLYB · Why this verdict
Why John Wiley & Sons (WLYB) is rated HOLD
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictHOLD
Overall score6.5/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The stock is exhibiting a volume surge at 2.7 times average with a rising on-balance volume reading and price above the 200-day moving average, indicating strong buying interest that has driven the momentum score to 8.3 out of 10. Momentum breakdown | Price momentum sustains over the next 6 months with RSI holding above 55 and volume remaining at least 1.5 times average on up days. | →Stable |
| CounterWith RSI currently at 72, the stock is technically overbought; momentum surges at overbought levels frequently lead to near-term pullbacks as short-term traders take profits. | ||
The stock is trading only 2.9% below its 52-week high with no meaningful upside remaining to the resistance price target, meaning the current price effectively reflects the full near-term value range the market is willing to assign. Bear case | Analyst consensus price targets are revised upward by more than 10% over 12 months, reopening a meaningful upside gap to justify holding through the current overbought reading. | →Stable |
| CounterStocks trading near 52-week highs with strong volume can continue to push higher as new buyers are attracted by the breakout signal; upside exhaustion is not guaranteed. | ||
The research segment accounts for approximately 64% of total revenues, creating significant concentration risk such that any negative shift in academic publishing economics could have an outsized impact on total company results. Bear case | Revenue diversification increases over 12 months, reducing research segment dependence to below 60% of total revenues. | →Stable |
| CounterA dominant position in academic research publishing can be a durable competitive advantage, as institutional libraries and researchers have limited substitutes for established journal brands. | ||
A Piotroski financial health score of 7 out of 9 reflects solid fundamentals across profitability, leverage, and operating efficiency, providing a quality foundation under the stock even as near-term price dynamics are challenging. Quality breakdown | The Piotroski score remains at 7 or above over the next 12 months, confirming financial health is maintained. | →Stable |
| CounterA Piotroski score of 7 is solid but not exceptional, and the Rule of 40 metric of 11 falls well below the 40-point threshold for software-adjacent businesses, indicating growth and profitability are not yet balanced. | ||
The stock is exhibiting a volume surge at 2.7 times average with a rising on-balance volume reading and price above the 200-day moving average, indicating strong buying interest that has driven the momentum score to 8.3 out of 10.
→StableMomentum breakdown
- Expectation
- Price momentum sustains over the next 6 months with RSI holding above 55 and volume remaining at least 1.5 times average on up days.
CounterWith RSI currently at 72, the stock is technically overbought; momentum surges at overbought levels frequently lead to near-term pullbacks as short-term traders take profits.
The stock is trading only 2.9% below its 52-week high with no meaningful upside remaining to the resistance price target, meaning the current price effectively reflects the full near-term value range the market is willing to assign.
→StableBear case
- Expectation
- Analyst consensus price targets are revised upward by more than 10% over 12 months, reopening a meaningful upside gap to justify holding through the current overbought reading.
CounterStocks trading near 52-week highs with strong volume can continue to push higher as new buyers are attracted by the breakout signal; upside exhaustion is not guaranteed.
The research segment accounts for approximately 64% of total revenues, creating significant concentration risk such that any negative shift in academic publishing economics could have an outsized impact on total company results.
→StableBear case
- Expectation
- Revenue diversification increases over 12 months, reducing research segment dependence to below 60% of total revenues.
CounterA dominant position in academic research publishing can be a durable competitive advantage, as institutional libraries and researchers have limited substitutes for established journal brands.
A Piotroski financial health score of 7 out of 9 reflects solid fundamentals across profitability, leverage, and operating efficiency, providing a quality foundation under the stock even as near-term price dynamics are challenging.
→StableQuality breakdown
- Expectation
- The Piotroski score remains at 7 or above over the next 12 months, confirming financial health is maintained.
CounterA Piotroski score of 7 is solid but not exceptional, and the Rule of 40 metric of 11 falls well below the 40-point threshold for software-adjacent businesses, indicating growth and profitability are not yet balanced.
TrendMatrix Research · core thesis
Engine thesis — one sentence
John Wiley and Sons Class B shares show strong near-term price momentum with volume surging 2.7 times average, but the stock is near its 52-week high with no remaining upside to resistance and heavy research segment concentration, making the risk-reward unfavorable for new buyers.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
6.6/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 9.2 |
| ROA | 4.5 |
| Gross margin | 10.0 |
| Op margin | 9.9 |
| Net margin | 6.6 |
| Current ratio | 2.2 |
| FCF quality | 6.6 |
| Moat | 6.4 |
| Rule of 40 | 3.0 |
| Piotroski F | 7.8 |
- ▸Excellent ROE: 28%
- ▸Rule of 40: 13 (fail)
- ▸Strong Piotroski F-Score: 7/9
Growth
6.4/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 2.8 |
| EPS growth | 10.0 |
Momentum
8.5/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.7 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 9.6 |
- ▸Overbought (RSI 86)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
5.0/10data confidence 67%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| erm sentiment | 5.0 |
Insider
5.0/10data confidence 50%Peer rank
5.2/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 6.7 |
| quality rank | 5.8 |
| growth rank | 3.3 |
- ▸Attractive P/E vs peers
Technical
3.5/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 0.0 |
| 52w position | 10.0 |
| gap | 4.0 |
Risk (lower is worse)
7.0/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 9.9 |
| days to cover | 3.1 |
| volatility | 8.1 |
| beta | 8.4 |
| debt equity | 5.6 |
- ▸Concentration risks: 2 HIGH, 3 MED (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
5.1/10data confidence 50%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| dividend safety | 5.2 |
- ▸Dividend: 271.0%
How the verdict was assembled
Engine trigger
Maintain position. Not compelling to add more.
Engine technical detail
verdict_path:
L4:PATH_F_HOLDPassed (6)
- MOMENTUM:8.5>=5.5
- INSIDER:OK
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:NO_DATE
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (0)
none
Warning (2)
- ASYMMETRY:UPSIDE_EXHAUSTED (upside=0.0%)
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
0.00
Upside
+0.0%
Downside
15.0%
Sizing output
AVOID
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityAggressive — MCap $2.7B<$5B
Investment implication
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: MOMENTUM:8.5>=5.5. Top dim: Value at 9.2; weakest: Technical at 3.5. No conviction either direction.
The strongest dimensions are Value at 9.2, Momentum at 8.5, and Risk (lower is worse) at 7.0; the weakest are Technical at 3.5, Insider at 5.0, and Sentiment at 5.0. The V9 engine cleared all gates with 2 warnings, producing an asymmetric reward-to-risk of 0.00 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Strong Momentum Volume Surge
Trip ifRSI falls below 40 within the next 3 months, signaling momentum has reversed from the current overbought reading.
- P2Upside Exhaustion Near High
Trip ifStock price drops below $40, more than 9% below the current $44.10, confirming upside exhaustion has led to a meaningful correction.
- P3Research Segment Concentration
Trip ifResearch segment revenue declines by more than 5% year-over-year in any reported quarter.
- P4Piotroski Financial Health
Trip ifPiotroski F-Score drops below 6 in any subsequent financial health measurement.